1d
The Institute for Clinical and Economic Review (ICER) released a report on Monday assessing the clinical effectiveness and ...
AstraZeneca’s new inhaler Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in Europe, as a maintenance treatment for chronic obstructive ...
Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance inhalers and offers medication management services, according to results ...
Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual condition management.
With a bewildering number of new drugs available for asthma and COPD, HCPs are increasingly making their decisions based on the cost and the inhaler device. They need to consider which inhaler ...
Hosted on MSN2d
Medical Report: Are asthma inhalers bad for the environment?Certain medications commonly used to treat asthma and COPD can damage the environment and worsen respiratory issues. KYW ...
Inhaler misuse leading to inadequate medication delivery impacts a person's ability to manage symptoms of chronic obstructive pulmonary disease (COPD), and additional education about proper ...
Emerging bronchodilators as the long-acting inhaled bifunctional muscarinic ... can minimize the incidences. The new Global Initiative for Obstructive Pulmonary Disease guidelines have a ...
A new study published in the CHEST journal found that ensifentrine, an innovative inhaled therapy, significantly reduces the ...
Medicare Part D and Medicare Advantage (Part C) plans with drug coverage typically cover inhalers for COPD. But you may still be responsible for a portion of the cost. If you have chronic ...
Inhalers may be prescribed to people who have a variety of health conditions both chronic and acute, including asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. If you're new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback